Table 2: Logistic Regression on the Association of MetS and VDD. MetS was used as outcome variable whereas vitD status was used as independent variable for individual risk outcomes describing MetS.

 

B

 

S.E.

 

Wald

 

df

 

p

 

OR

95% C.I. for OR

 

Lower

Upper

MetS

 

 

 

 

 

 

 

 

25(OH)D ≥5 ng/ml

0.9

0.5

3

1

0.081

2.5

0.9

7.0

25(OH)D ≥10 ng/ml

-0.2

0.1

2

1

0.133

0.8

0.7

1.1

25(OH)D ≥20 ng/ml

-0.3

0.1

17

1

0.000

0.7

0.6

0.8

25(OH)D ≥30 ng/ml

-0.1

0.1

1

1

0.370

0.9

0.7

1.1

WC

 

 

 

 

 

 

 

 

25(OH)D ≥5 ng/ml

0.2

0.3

1

1

0.418

1.3

0.7

2.2

25(OH)D ≥10 ng/ml

-0.5

0.1

41

1

0.000

0.6

0.5

0.7

25(OH)D ≥20 ng/ml

-0.4

0.1

51

1

0.000

0.7

0.6

0.8

25(OH)D ≥30 ng/ml

-0.2

0.1

5

1

0.024

0.8

0.7

1.0

HDL

 

 

 

 

 

 

 

 

25(OH)D ≥5 ng/ml

0.1

0.3

0

1

0.791

1.1

0.6

2.0

25(OH)D ≥10 ng/ml

-0.1

0.1

1

1

0.438

0.9

0.8

1.1

25(OH)D ≥20 ng/ml

-0.1

0.1

5

1

0.029

0.9

0.8

1.0

25(OH)D ≥30 ng/ml

-0.4

0.1

19

1

0.000

0.7

0.6

0.8

TG

 

 

 

 

 

 

 

 

25(OH)D ≥5 ng/ml

0.6

0.6

1

1

0.335

1.8

0.5

6.3

25(OH)D ≥10 ng/ml

0.3

0.1

5

1

0.029

1.4

1.0

1.8

25(OH)D ≥20 ng/ml

0.1

0.1

2

1

0.123

1.2

1.0

1.4

25(OH)D ≥30 ng/ml

0.1

0.1

0

1

0.554

1.1

0.8

1.4

FBG

 

 

 

 

 

 

 

 

25(OH)D ≥5 ng/ml

0.3

0.4

1

1

0.463

1.4

0.6

3.3

25(OH)D ≥10 ng/ml

0.0

0.1

0

1

0.785

1.0

0.8

1.3

25(OH)D ≥20 ng/ml

-0.1

0.1

2

1

0.168

0.9

0.7

1.1

25(OH)D ≥30 ng/ml

-0.2

0.1

3

1

0.109

0.8

0.7

1.0

BP

 

 

 

 

 

 

 

 

25(OH)D ≥5 ng/ml

1.0

0.4

5

1

0.022

2.8

1.2

6.6

25(OH)D ≥10 ng/ml

-0.2

0.1

3

1

0.069

0.8

0.7

1.0

25(OH)D ≥20 ng/ml

-0.1

0.1

5

1

0.029

0.9

0.8

1.0

25(OH)D ≥30 ng/ml

0.0

0.1

0

1

0.856

1.0

0.8

1.2